ALEC
Price
$1.48
Change
-$0.02 (-1.33%)
Updated
Jun 27 closing price
Capitalization
147.99M
33 days until earnings call
EYPT
Price
$9.64
Change
-$0.73 (-7.04%)
Updated
Jun 27 closing price
Capitalization
664.03M
32 days until earnings call
Interact to see
Advertisement

ALEC vs EYPT

Header iconALEC vs EYPT Comparison
Open Charts ALEC vs EYPTBanner chart's image
Alector
Price$1.48
Change-$0.02 (-1.33%)
Volume$2.12M
Capitalization147.99M
EyePoint Pharmaceuticals
Price$9.64
Change-$0.73 (-7.04%)
Volume$1.83M
Capitalization664.03M
ALEC vs EYPT Comparison Chart in %
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. EYPT commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and EYPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ALEC: $1.48 vs. EYPT: $9.64)
Brand notoriety: ALEC and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 227% vs. EYPT: 220%
Market capitalization -- ALEC: $147.99M vs. EYPT: $664.03M
ALEC [@Biotechnology] is valued at $147.99M. EYPT’s [@Biotechnology] market capitalization is $664.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 3 TA indicator(s) are bullish while EYPT’s TA Score has 4 bullish TA indicator(s).

  • ALEC’s TA Score: 3 bullish, 3 bearish.
  • EYPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ALEC and EYPT are a good buy in the short-term.

Price Growth

ALEC (@Biotechnology) experienced а +0.68% price change this week, while EYPT (@Biotechnology) price change was +14.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ALEC is expected to report earnings on Jul 31, 2025.

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($664M) has a higher market cap than ALEC($148M). EYPT YTD gains are higher at: 29.396 vs. ALEC (-21.693). ALEC (-137.59M) and EYPT (-144.55M) have comparable annual earnings (EBITDA) . ALEC has more cash in the bank: 355M vs. EYPT (318M). EYPT has less debt than ALEC: EYPT (24.1M) vs ALEC (41M). ALEC has higher revenues than EYPT: ALEC (88.3M) vs EYPT (56M).
ALECEYPTALEC / EYPT
Capitalization148M664M22%
EBITDA-137.59M-144.55M95%
Gain YTD-21.69329.396-74%
P/E RatioN/AN/A-
Revenue88.3M56M158%
Total Cash355M318M112%
Total Debt41M24.1M170%
FUNDAMENTALS RATINGS
ALEC vs EYPT: Fundamental Ratings
ALEC
EYPT
OUTLOOK RATING
1..100
7379
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
5535
P/E GROWTH RATING
1..100
9417
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALEC's Valuation (51) in the Biotechnology industry is in the same range as EYPT (61) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's Profit vs Risk Rating (93) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ALEC’s over the last 12 months.

EYPT's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ALEC’s over the last 12 months.

EYPT's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as ALEC (55) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ALEC’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for ALEC (94) in the Biotechnology industry. This means that EYPT’s stock grew significantly faster than ALEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECEYPT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASGOF1.160.02
+2.11%
Asante Gold Corp
ZLDPF56.111.06
+1.92%
Zealand Pharma A/S
SVJTY21.90N/A
N/A
Severstal PAO
MKTDF0.03N/A
N/A
Deepmarkit Corp.
FCSUF0.12N/A
N/A
Focus Minerals Ltd.

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
-1.33%
RGNX - ALEC
50%
Loosely correlated
-4.11%
BEAM - ALEC
50%
Loosely correlated
-1.98%
DNLI - ALEC
47%
Loosely correlated
-2.69%
ABCL - ALEC
47%
Loosely correlated
-3.48%
EYPT - ALEC
47%
Loosely correlated
-7.04%
More

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-7.04%
OCUL - EYPT
64%
Loosely correlated
-2.54%
LYRA - EYPT
58%
Loosely correlated
-31.91%
BEAM - EYPT
57%
Loosely correlated
-1.98%
CRSP - EYPT
54%
Loosely correlated
+1.69%
ATHE - EYPT
54%
Loosely correlated
+0.34%
More